Mindful Care partners with NeuroKaire to offer an AI-driven blood test that predicts which antidepressant will work best for each…
Tempus AI adds Personalis' liquid biopsy and tumor sequencing capabilities in a $1.5 billion acquisition.
A deep learning model predicts aggressive liver cancer from CT scans across 3,100 patients, potentially replacing biopsies for treatment selection.
ARPA-H has awarded up to $160 million to seven research teams to build AI-driven platforms for creating custom, individualized gene…
The 2026 MIT Technology Review list highlights a first-in-human personalized gene editing trial that will reshape pharmaceutical workflows and force…